|
| Commodity | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 |
| Phenazone (antipyrin) & its derivs. | $9,446,437 | $11,092,932 | $12,980,021 | $16,538,602 | $8,031,945 | $11,423,749 | $12,156,566 |
| Heterocyclic comps. cont. an unfused pyrazole ring (whether or not hydrogen ... | $91,630,801 | $104,961,427 | $109,369,988 | $151,355,943 | $171,074,958 | $237,821,736 | $276,819,809 |
| Hydantoin & its derivs. | $2,360,053 | $3,934,986 | $10,276,578 | $17,319,578 | $18,499,463 | $24,878,888 | $22,378,701 |
| Heterocyclic comps. cont. an unfused imidazole ring (whether or not hydroge ... | $95,761,193 | $111,335,935 | $138,080,068 | $199,625,811 | $184,115,664 | $191,723,415 | $254,285,360 |
| Pyridine & its salts | $16,112,260 | $27,678,011 | $27,335,869 | $37,416,114 | $39,884,185 | $40,751,207 | $38,038,748 |
| Heterocyclic comps. cont. an unfused pyridine ring (whether or not hydrogen ... | $78,585,161 | $200,488,616 | $395,402,997 | $619,970,551 | $618,345,360 | $695,963,885 | $1,012,805,829 |
| Heterocyclic comps. cont. a pyrimidine ring (whether or not hydrogenated)/p ... | $121,263,722 | $148,129,117 | $167,808,948 | $212,171,849 | $235,666,130 | $290,155,592 | $434,802,219 |
| Melamine | $82,292,016 | $88,635,203 | $132,377,937 | $228,856,845 | $111,466,529 | $180,962,844 | $233,239,206 |
| Heterocyclic comps. cont. an unfused triazine ring (whether or not hydrogen ... | $168,768,828 | $290,330,538 | $384,521,357 | $657,519,026 | $442,419,350 | $553,426,954 | $650,546,739 |
| 6-Hexanelactam (epsilon-caprolactam) | $4,433,281 | $90,959 | $90,026 | $4,562,729 | $3,261,859 | $1,601,696 | $26,664,869 |
| Lactams (excl. of 2933.71 & 2933.72) | $18,514,529 | $27,081,153 | $47,623,623 | $65,469,788 | $72,558,088 | $102,048,881 | $146,702,907 |
| Total | $689,168,281 | $1,013,758,877 | $1,425,867,412 | $2,210,806,836 | $1,905,323,531 | $2,330,758,847 | $3,108,440,953 |
|
|
